Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasodilatory Effect of GLP-1
NCT03502083Completed
- Start
- Dec 2015
- Primary completion
- Mar 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
01
Overview
Randomised, double-blind trial of Glucagon-like peptide 1(7-36)-amide in coronary stenosis (4 arms). Primary endpoints: Change in Index of Microcirculatory Resistance and Forearm blood flow ratio. Started Dec 2015; status: completed.
02
Drugs
Glucagon-like peptide 1(7-36)-amide
03
Conditions
coronary stenosis
Beyond the preview
Go deeper on NCT03502083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03502083.